| Financial Year |
March 31 2023 |
| Monetary Funds |
646,278,357.71 |
| Held-for-trading Financial Assets |
20,062,885.73 |
| Notes Receivable |
56,872,238.82 |
| Accounts Receivable |
412,635,503.53 |
| Advances to Suppliers |
42,477,746.78 |
| Other Receivables |
15,643,275.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
202,204,352.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,208,124.80 |
| Total Current Assets |
1,581,200,522.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,368,137.40 |
| Investment Properties |
7,996,730.93 |
| Fixed Assetes |
1,001,243,925.81 |
| Under-construction Projects |
55,675,419.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,608,451.31 |
| R&D expenses |
-- |
| Goodwill |
299,058,864.97 |
| Long-Term Deferred and Prepaid Expenses |
1,622,615.68 |
| Deferred Income Tax Assets |
30,974,379.17 |
| Other Non-Current Assets |
5,123,013.13 |
| Sub-Total of Non-Current Assets |
1,594,476,669.67 |
| Total Assets |
3,175,677,192.50 |
| Short-Term Loans |
19,931,695.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,980,000.00 |
| Accounts Payable |
181,645,422.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,771,406.67 |
| Taxes Payable |
33,641,632.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
187,040,230.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,315,530.76 |
| Other Current Liabilities |
5,127,489.60 |
| Sub-Total of Current Liabilities |
542,895,636.26 |
| Long-term Loans |
207,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,515,027.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
234,266,771.36 |
| Total Liabilities |
777,162,407.62 |
| Paid-In Capital(Or Share Stock) |
534,071,628.00 |
| Capital Surplus |
968,991,229.37 |
| Surplus Reserve |
72,334,633.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
759,586,940.46 |
| Minority Stockholder's Interest |
45,286,838.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,353,227,946.64 |
| Owner's Equity（Stockholder's Equity） |
2,398,514,784.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,175,677,192.50 |
